Effectiveness and Safety Study of Filgrastine® in Patientes With Breast Cancer Treated With Myelotoxic Chemotherapy

NCT05790096 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

BIOLOGICAL: Granulokine
BIOLOGICAL: Filgrastine

Sponsor

Blau Farmaceutica S.A.